PUBLIC CONTRACT · 2015

Medicamentos de consumo geral: medicamentos usados nas afecções oculares e otorrinolaringológicas - C/ Base no CPA 2013/49

Contract value
€6,662.12
Signed on
18 March 2015
Procedure
Direct award, general (Ajuste Direto Regime Geral)

This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.

Record 2259508

PUBLISHED DESCRIPTION

060100172015

Parties involved

Place of performance
Portugal, Coimbra, Coimbra
NUTS region
Not stated

WHO BID

Awardee and competitors

Companies that IMPIC lists as the awardee and as competitors in this procedure.

Awardee
Laboratórios Edol, SA · Tax ID 507072642
Awardee
Davi II Farmacêutica, SA · Tax ID 508309450
Awardee
Aurovitas Unipessoal, Ld.a · Tax ID 513053239
Awardee
Merck Sharp & Dohme, Ld.a · Tax ID 500191360
Bidder
Laboratórios Pfizer, Lda. · Tax ID 500162166
Bidder
GENERIS Farmacêutica, SA · Tax ID 508107997

Values and timeline

Contract price
€6,662.12
Procedure base price
€0.00
Total effective price
€7,980.92
Publication date
27 June 2016
Award date
18 March 2015
Signing date
18 March 2015
Performance period
365 days

The contract price is the value agreed in the contract, not the amount paid.

Procedure and framework

Contract type
Aquisição de bens móveis
Award criterion
Not stated
CPV code
33698000-9 - Produtos para fins clínicos
Legal basis
Artigo 258.º do Código dos Contratos Públicos
Regime
Código dos Contratos Públicos (DL 18/2008)
Framework agreement
Not stated
Centralised procedure
No
Environmental criterion
No
Notice
Not stated
Procedure identifier
1325537

Compare with other contracts

Search the same body, supplier, place or type of service to understand the context of the published index.

← Back to contracts